FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147216101> ?p ?o ?g. }

• W3147216101 endingPage "1556" @default.
• W3147216101 startingPage "1536" @default.
• W3147216101 abstract "Treatment of advanced non-small cell lung cancer (NSCLC) has radically improved in the last years due to development and clinical approval of highly effective agents including immune checkpoint inhibitors (ICIs) and oncogene-directed therapies. Molecular profiling of lung cancer samples for activated oncogenes, including epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1) and BRAF, is routinely performed to select the most appropriate up-front treatment. However, the identification of new therapeutic targets remains a high priority. Recently, MET exon 14 skipping mutations have emerged as novel actionable oncogenic alterations in NSCLC, sensitive to MET inhibition. In this review we discuss: (I) MET gene and MET receptor structure and signaling pathway; (II) MET exon 14 alterations; (III) current data on MET inhibitors, mainly focusing on selective MET tyrosine kinase inhibitors (TKIs), in the treatment of NSCLC with MET exon 14 skipping mutations. We identified the references for this review through a literature search of papers about MET, MET exon 14 skipping mutations, and MET inhibitors, published up to September 2020, by using PubMed, Scopus and Web of Science databases. We also searched on websites of main international cancer congresses (ASCO, ESMO, IASLC) for ongoing studies presented as abstracts. MET exon 14 skipping mutations have been associated with clinical activity of selective MET inhibitors, including capmatinib, that has recently received approval by FDA for clinical use in this subgroup of NSCLC patients. A large number of trials are testing MET inhibitors, also in combinatorial therapeutic strategies, in MET exon 14-altered NSCLC. Results from these trials are eagerly awaited to definitively establish the role and setting for use of these agents in NSCLC patients." @default.
• W3147216101 created "2021-04-13" @default.
• W3147216101 creator A5007625475 @default.
• W3147216101 creator A5013748999 @default.
• W3147216101 creator A5019233591 @default.
• W3147216101 creator A5031753406 @default.
• W3147216101 creator A5044887899 @default.
• W3147216101 creator A5059144188 @default.
• W3147216101 creator A5086182688 @default.
• W3147216101 date "2021-03-01" @default.
• W3147216101 modified "2023-10-14" @default.
• W3147216101 title "A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations" @default.
• W3147216101 cites W117902596 @default.
• W3147216101 cites W174497121 @default.
• W3147216101 cites W1850419181 @default.
• W3147216101 cites W1852811144 @default.
• W3147216101 cites W1964261321 @default.
• W3147216101 cites W1975784282 @default.
• W3147216101 cites W1985995844 @default.
• W3147216101 cites W1990516512 @default.
• W3147216101 cites W1990626198 @default.
• W3147216101 cites W1994912526 @default.
• W3147216101 cites W1999740664 @default.
• W3147216101 cites W2011721336 @default.
• W3147216101 cites W2012792646 @default.
• W3147216101 cites W2018336040 @default.
• W3147216101 cites W2021625070 @default.
• W3147216101 cites W2037968180 @default.
• W3147216101 cites W2039491462 @default.
• W3147216101 cites W2049332675 @default.
• W3147216101 cites W2050249255 @default.
• W3147216101 cites W2050825441 @default.
• W3147216101 cites W2053343049 @default.
• W3147216101 cites W2054042846 @default.
• W3147216101 cites W2055787036 @default.
• W3147216101 cites W2066852162 @default.
• W3147216101 cites W2080935320 @default.
• W3147216101 cites W2086454484 @default.
• W3147216101 cites W2092225298 @default.
• W3147216101 cites W2094337993 @default.
• W3147216101 cites W2099530756 @default.
• W3147216101 cites W2099857141 @default.
• W3147216101 cites W2100891825 @default.
• W3147216101 cites W2100945326 @default.
• W3147216101 cites W2107763333 @default.
• W3147216101 cites W2114556798 @default.
• W3147216101 cites W2121262970 @default.
• W3147216101 cites W2138309116 @default.
• W3147216101 cites W2151512523 @default.
• W3147216101 cites W2155103465 @default.
• W3147216101 cites W2156617256 @default.
• W3147216101 cites W2158424267 @default.
• W3147216101 cites W2159426719 @default.
• W3147216101 cites W2160212814 @default.
• W3147216101 cites W2160725767 @default.
• W3147216101 cites W2162621952 @default.
• W3147216101 cites W2163351155 @default.
• W3147216101 cites W2169477367 @default.
• W3147216101 cites W2169624569 @default.
• W3147216101 cites W2170259414 @default.
• W3147216101 cites W2180481128 @default.
• W3147216101 cites W2230948985 @default.
• W3147216101 cites W2254709940 @default.
• W3147216101 cites W2272081149 @default.
• W3147216101 cites W2281622498 @default.
• W3147216101 cites W2308285449 @default.
• W3147216101 cites W2327451947 @default.
• W3147216101 cites W2328238139 @default.
• W3147216101 cites W2399141972 @default.
• W3147216101 cites W2409383155 @default.
• W3147216101 cites W2466657922 @default.
• W3147216101 cites W2475363814 @default.
• W3147216101 cites W2521720507 @default.
• W3147216101 cites W2526076440 @default.
• W3147216101 cites W2547345470 @default.
• W3147216101 cites W2549689857 @default.
• W3147216101 cites W2551187851 @default.
• W3147216101 cites W2562169753 @default.
• W3147216101 cites W2587620487 @default.
• W3147216101 cites W2618497753 @default.
• W3147216101 cites W2625634490 @default.
• W3147216101 cites W2737371788 @default.
• W3147216101 cites W2740630940 @default.
• W3147216101 cites W2751653911 @default.
• W3147216101 cites W2754451013 @default.
• W3147216101 cites W2769006626 @default.
• W3147216101 cites W2770845897 @default.
• W3147216101 cites W2779968640 @default.
• W3147216101 cites W2784623697 @default.
• W3147216101 cites W2792961879 @default.
• W3147216101 cites W2802552316 @default.
• W3147216101 cites W2825280821 @default.
• W3147216101 cites W285988926 @default.
• W3147216101 cites W2885387864 @default.
• W3147216101 cites W2889307896 @default.
• W3147216101 cites W2896528728 @default.
• W3147216101 cites W2896617057 @default.
• W3147216101 cites W2897073503 @default.

• next